FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders.

Saved in:
Bibliographic Details
Title: FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders.
Authors: Lui, Austin1 (AUTHOR), Vanleuven, Jordan1 (AUTHOR), Perekopskiy, David1 (AUTHOR), Liu, Dewey1 (AUTHOR), Xu, Desiree1 (AUTHOR), Alzayat, Omar1 (AUTHOR), Elgokhy, Taiseer1 (AUTHOR), Do, Timothy1 (AUTHOR), Gann, Meghan1 (AUTHOR), Martin, Ryan2 (AUTHOR), Liu, Da-Zhi1,3 (AUTHOR) dzliu@ucdavis.edu
Source: Pharmaceuticals (14248247). Dec2022, Vol. 15 Issue 12, p1546. 30p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14248247
DOI:10.3390/ph15121546